Assessment of the compatibility of the real-world nonvalvular atrial fibrillation patients in Turkey with the study population of Phase 3 novel oral anticoagulant trials: An auxiliary study of NOAC-TR

EMREN S. V., ZOGHİ M., Karagöz U., Inci S., Açiksari G., BEKAR L., ...Daha Fazla

International Journal of the Cardiovascular Academy, cilt.6, sa.1, ss.12-15, 2020 (Scopus)